BIO-Europe 2026
Talk Presenting Companies (Theatre A) track
Dermatology: Alphyn Biologics
Mon, Nov 9, 2026 · 4:45–5:00 PM CET Koelnmesse
About this session
Alphyn is a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics® (MTT™) for severe and prevalent skin diseases based on our Zabalafin Platform (AB-101 Platform). We are dedicated to improving the lives of millions of patients worldwide with Multi-Target Therapeutics that are expected to be safe, powerful, and more effectively attack disease.
Speaker
-
CEO and Chairman of the Board · Alphyn Biologics
Speaker